These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16101149)

  • 1. Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells.
    Koizumi K; Tanno S; Nakano Y; Habiro A; Izawa T; Mizukami Y; Okumura T; Kohgo Y
    Anticancer Res; 2005; 25(5):3347-53. PubMed ID: 16101149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells.
    Habiro A; Tanno S; Koizumi K; Izawa T; Nakano Y; Osanai M; Mizukami Y; Okumura T; Kohgo Y
    Biochem Biophys Res Commun; 2004 Mar; 316(1):71-7. PubMed ID: 15003513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
    Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
    Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
    Liu F; Gore AJ; Wilson JL; Korc M
    PLoS One; 2014; 9(1):e84982. PubMed ID: 24409315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.
    Ng SSW ; Tsao MS; Chow S; Hedley DW
    Cancer Res; 2000 Oct; 60(19):5451-5. PubMed ID: 11034087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.
    Bu HQ; Luo J; Chen H; Zhang JH; Li HH; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2012 Sep; 41(3):949-58. PubMed ID: 22710877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
    Yokoi K; Fidler IJ
    Clin Cancer Res; 2004 Apr; 10(7):2299-306. PubMed ID: 15073105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines.
    Kao YT; Hsu WC; Hu HT; Hsu SH; Lin CS; Chiu CC; Lu CY; Hour TC; Pu YS; Huang AM
    Kaohsiung J Med Sci; 2014 Jul; 30(7):323-30. PubMed ID: 24924837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.
    Zhao Y; Shen S; Guo J; Chen H; Greenblatt DY; Kleeff J; Liao Q; Chen G; Friess H; Leung PS
    J Surg Res; 2006 Dec; 136(2):325-35. PubMed ID: 17054996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells.
    Cheng X; Holenya P; Can S; Alborzinia H; Rubbiani R; Ott I; Wölfl S
    Mol Cancer; 2014 Sep; 13():221. PubMed ID: 25253202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
    Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH
    Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
    Muniyappa H; Das KC
    Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.
    Köpper F; Binkowski AM; Bierwirth C; Dobbelstein M
    Cell Cycle; 2014; 13(6):884-9. PubMed ID: 24556918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
    Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinases.
    Wang W; Waters SJ; MacDonald JR; Roth C; Shentu S; Freeman J; Von Hoff DD; Miller AR
    Anticancer Res; 2002; 22(2A):559-64. PubMed ID: 12014623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.
    Arlt A; Gehrz A; Müerköster S; Vorndamm J; Kruse ML; Fölsch UR; Schäfer H
    Oncogene; 2003 May; 22(21):3243-51. PubMed ID: 12761494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic stellate cell activation by ethanol and acetaldehyde: is it mediated by the mitogen-activated protein kinase signaling pathway?
    McCarroll JA; Phillips PA; Park S; Doherty E; Pirola RC; Wilson JS; Apte MV
    Pancreas; 2003 Aug; 27(2):150-60. PubMed ID: 12883264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
    Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
    Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells.
    Hirahara N; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tajima Y
    Anticancer Res; 2012 Jul; 32(7):2631-7. PubMed ID: 22753720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
    Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D
    World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.